Literature DB >> 26057784

Intracranial Aneurysms: Recurrences More than 10 Years after Endovascular Treatment-A Prospective Cohort Study, Systematic Review, and Meta-Analysis.

Augustin Lecler1, Jean Raymond1, Christine Rodriguez-Régent1, Fawaz Al Shareef1, Denis Trystram1, Sylvie Godon-Hardy1, Wagih Ben Hassen1, Jean-François Meder1, Catherine Oppenheim1, Olivier N Naggara1.   

Abstract

PURPOSE: To assess the efficacy of endovascular treatment (EVT) of intracranial aneurysms for recurrence, bleeding, and de novo aneurysm formation at long-term follow-up (> 10 years after treatment) with magnetic resonance (MR) angiography and to identify risk factors for recurrence through a prospective study and a systematic review of the literature.
MATERIALS AND METHODS: Clinical examinations and 3-T MR angiography were performed prospectively 10 years after EVT of intracranial aneurysms in a single institution. Ethics committee approval and informed consent were obtained. PubMed, EMBASE, and Cochrane databases were searched to identify studies in which authors reported bleeding and/or aneurysm recurrence rates in patients who received follow-up more than 10 years after EVT. Univariate and multivariate subgroup analyses were performed to identify risk factors (midterm MR angiographic results, aneurysm characteristics, retreatment within 5 years).
RESULTS: In the prospective study, sac recanalization occurred between midterm and long-term MR angiography in 16 of 129 (12.4%) aneurysms. Grade 2 classification on the Raymond scale at midterm MR angiography (relative risk [RR], 4.16; 99% confidence interval [CI]: 2.12, 8.14) and retreatment within 5 years (RR, 4.67; 99% CI: 1.55, 14.03) were risk factors for late recurrence. In the systematic review (15 cohorts, 2773 patients, 2902 aneurysms), bleeding, aneurysm recurrence, and de novo lesion formation rates were, respectively, 0.7% (99% CI: 0.2%, 2.7%; I(2), 0%; one of 694 patients), 11.4% (99% CI: 7.0%, 18.0%; I(2), 21.6%), and 4.1% (99% CI: 1.7, 9.4%; I(2), 54.1%). Raymond grade 2 initial result (RR, 7.08; 99% CI: 1.24, 40.37; I(2), 82.6%) and aneurysm size greater than 10 mm (RR, 4.37; 99% CI: 1.83, 10.44; I(2), 0%) were risk factors for late recurrence.
CONCLUSION: EVT of intracranial aneurysm is effective for prevention of long-term bleeding, but recurrences occur in a clinically relevant percentage of patients, a finding that may justify follow-up of selected patients for 10 years or more, such as patients with aneurysms larger than 10 mm or classified as Raymond grade 2 at midterm MR angiography. (©) RSNA, 2015 Online supplemental material is available for this article.

Entities:  

Mesh:

Year:  2015        PMID: 26057784     DOI: 10.1148/radiol.2015142496

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  26 in total

1.  The clinical value of ceMRA versus DSA for follow-up of intracranial aneurysms treated by coil embolization: an assessment of occlusion classifications and impact on treatment decisions.

Authors:  Maximilian Patzig; Robert Forbrig; Margaretha Gruber; Thomas Liebig; Franziska Dorn
Journal:  Eur Radiol       Date:  2020-11-21       Impact factor: 5.315

2.  Suspected Metallic Embolization Distal to Coiled Intracranial Aneurysms Detectable by Susceptibility-Weighted MR Imaging.

Authors:  D H Yoo; Y D Cho; H S Lee; S H Kim; D Jang; S H Lee; W-S Cho; H-S Kang; J E Kim; M H Han
Journal:  AJNR Am J Neuroradiol       Date:  2020-04       Impact factor: 3.825

3.  Aneurysm Remnants after Flow Diversion: Clinical and Angiographic Outcomes.

Authors:  T P Madaelil; J A Grossberg; B M Howard; C M Cawley; J Dion; R G Nogueira; D C Haussen; F C Tong
Journal:  AJNR Am J Neuroradiol       Date:  2019-03-07       Impact factor: 3.825

4.  Risk factor analysis of recanalization and retreatment for patients with endovascular treatment of internal carotid artery bifurcation aneurysms.

Authors:  Seung Pil Ban; Gyojun Hwang; Chang Hyeun Kim; Hyoung Soo Byoun; Si Un Lee; Tackeun Kim; Jae Seung Bang; Chang Wan Oh; O-Ki Kwon
Journal:  Neuroradiology       Date:  2018-03-23       Impact factor: 2.804

5.  Endovascular treatment of aneurysms and platinum coil caliber: Study protocol of a randomized, controlled trial.

Authors:  Jimmy Ghostine; Naim Khoury; Francis Cloutier; Marc Kotowski; Jean-Christophe Gentric; André L Batista; Alain Weill; Daniel Roy; Tim E Darsaut; Jean Raymond
Journal:  Interv Neuroradiol       Date:  2016-08-16       Impact factor: 1.610

6.  Predisposing factors for recanalization of cerebral aneurysms after endovascular embolization: a multivariate study.

Authors:  Qianqian Zhang; Linkai Jing; Jian Liu; Kun Wang; Ying Zhang; Nikhil Paliwal; Hui Meng; Yang Wang; Shengzhang Wang; Xinjian Yang
Journal:  J Neurointerv Surg       Date:  2017-04-04       Impact factor: 5.836

7.  Hemodynamic Characteristics Regarding Recanalization of Completely Coiled Aneurysms: Computational Fluid Dynamic Analysis Using Virtual Models Comparison.

Authors:  Wonhyoung Park; Yunsun Song; Kye Jin Park; Hae-Won Koo; Kuhyun Yang; Dae Chul Suh
Journal:  Neurointervention       Date:  2016-03-03

8.  Comparing Morphology and Hemodynamics of Stable-versus-Growing and Grown Intracranial Aneurysms.

Authors:  E L Leemans; B M W Cornelissen; C H Slump; C B L M Majoie; J R Cebral; H A Marquering
Journal:  AJNR Am J Neuroradiol       Date:  2019-11-28       Impact factor: 3.825

9.  Does Increasing Packing Density Using Larger Caliber Coils Improve Angiographic Results of Embolization of Intracranial Aneurysms at 1 Year: A Randomized Trial.

Authors:  J Raymond; J Ghostine; B A van Adel; J J S Shankar; D Iancu; A P Mitha; P Kvamme; R D Turner; A Turk; V Mendes-Pereira; J S Carpenter; S Boo; A Evans; H H Woo; D Fiorella; A Alaraj; D Roy; A Weill; P Lavoie; M Chagnon; T N Nguyen; J L Rempel; T E Darsaut
Journal:  AJNR Am J Neuroradiol       Date:  2020-01-02       Impact factor: 3.825

10.  Early major recurrence of cerebral aneurysms after satisfactory initial coiling.

Authors:  Mohamad Abdalkader; Jean Raymond; Asim Mian; Varun Naragum; Katharine Cronk; Daniel Roy; Alain Weill; Thanh N Nguyen
Journal:  Interv Neuroradiol       Date:  2020-10-20       Impact factor: 1.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.